Jane I. Grove1,2† , Camilla Stephens3,4† , M. Isabel Lucena3,4 , Raúl J. Andrade3,4 , Sabine Weber5, Alexander Gerbes5 , Einar S. Bjornsson6,7 , Guido Stirnimann8 , Ann K. Daly9 , Matthias Hackl10 , Kseniya Khamina‑Kotisch10 , Jose J. G. Marin4,11, Maria J
(2023)
Advances in Biomarkers: pp.
80-95.
Chapter 7
Study design for development of novel
safety biomarkers of drug‑induced liver injury
by the translational safety biomarker pipeline
(TransBioLine) consortium: a study protocol
for a nested case–control study